GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Esr2
|
ENSMUSG00000021055.7 | estrogen receptor 2 (beta) |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Esr2 | mm10_v2_chr12_-_76177251_76177265 | -0.46 | 5.0e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_46235260 | 9.05 |
ENSMUST00000121916.1
ENSMUST00000034586.2 |
Apoc3
|
apolipoprotein C-III |
chr11_-_5915124 | 8.54 |
ENSMUST00000109823.2
ENSMUST00000109822.1 |
Gck
|
glucokinase |
chr9_+_46268601 | 7.83 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chr9_-_46235631 | 6.57 |
ENSMUST00000118649.1
|
Apoc3
|
apolipoprotein C-III |
chr1_-_180193653 | 6.01 |
ENSMUST00000159914.1
|
Adck3
|
aarF domain containing kinase 3 |
chr7_-_46742979 | 5.58 |
ENSMUST00000128088.1
|
Saa1
|
serum amyloid A 1 |
chr2_+_102658640 | 5.42 |
ENSMUST00000080210.3
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr2_+_102706356 | 5.21 |
ENSMUST00000123759.1
ENSMUST00000111212.1 ENSMUST00000005220.4 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr5_-_146009598 | 4.62 |
ENSMUST00000138870.1
ENSMUST00000068317.6 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr7_+_27119909 | 4.58 |
ENSMUST00000003100.8
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr7_-_48848023 | 4.51 |
ENSMUST00000032658.6
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr7_+_140763739 | 4.39 |
ENSMUST00000026552.7
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr5_+_146079254 | 4.31 |
ENSMUST00000035571.8
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr8_-_72212837 | 4.30 |
ENSMUST00000098630.3
|
Cib3
|
calcium and integrin binding family member 3 |
chr17_-_46438471 | 4.21 |
ENSMUST00000087012.5
|
Slc22a7
|
solute carrier family 22 (organic anion transporter), member 7 |
chr10_-_128960965 | 4.13 |
ENSMUST00000026398.3
|
Mettl7b
|
methyltransferase like 7B |
chr11_+_72435511 | 3.97 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr11_+_72435565 | 3.93 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr15_-_82764176 | 3.88 |
ENSMUST00000055721.4
|
Cyp2d40
|
cytochrome P450, family 2, subfamily d, polypeptide 40 |
chr12_+_104338372 | 3.88 |
ENSMUST00000101078.5
ENSMUST00000043058.3 |
Serpina3m
Serpina3k
|
serine (or cysteine) peptidase inhibitor, clade A, member 3M serine (or cysteine) peptidase inhibitor, clade A, member 3K |
chr6_+_90550789 | 3.84 |
ENSMUST00000130418.1
ENSMUST00000032175.8 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr2_+_173153048 | 3.84 |
ENSMUST00000029017.5
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr11_+_72435534 | 3.83 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr14_-_34355383 | 3.72 |
ENSMUST00000052126.5
|
Fam25c
|
family with sequence similarity 25, member C |
chr8_+_104867488 | 3.69 |
ENSMUST00000043209.9
|
Ces2d-ps
|
carboxylesterase 2D, pseudogene |
chr11_-_5950018 | 3.64 |
ENSMUST00000102920.3
|
Gck
|
glucokinase |
chr9_+_46269069 | 3.63 |
ENSMUST00000034584.3
|
Apoa5
|
apolipoprotein A-V |
chr17_-_34000257 | 3.61 |
ENSMUST00000087189.6
ENSMUST00000173075.1 ENSMUST00000172760.1 ENSMUST00000172912.1 ENSMUST00000025181.10 |
H2-K1
|
histocompatibility 2, K1, K region |
chr7_+_127800604 | 3.54 |
ENSMUST00000046863.5
ENSMUST00000106272.1 ENSMUST00000139068.1 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr18_-_61911783 | 3.52 |
ENSMUST00000049378.8
ENSMUST00000166783.1 |
Ablim3
|
actin binding LIM protein family, member 3 |
chr19_-_4498574 | 3.51 |
ENSMUST00000048482.6
|
2010003K11Rik
|
RIKEN cDNA 2010003K11 gene |
chr7_+_46751832 | 3.47 |
ENSMUST00000075982.2
|
Saa2
|
serum amyloid A 2 |
chr7_+_127800844 | 3.44 |
ENSMUST00000106271.1
ENSMUST00000138432.1 |
Hsd3b7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr7_+_44384803 | 3.35 |
ENSMUST00000120262.1
|
Syt3
|
synaptotagmin III |
chr7_-_119523477 | 3.34 |
ENSMUST00000033267.2
|
Pdilt
|
protein disulfide isomerase-like, testis expressed |
chr1_-_180193475 | 3.32 |
ENSMUST00000160482.1
ENSMUST00000170472.1 |
Adck3
|
aarF domain containing kinase 3 |
chr2_-_25501717 | 3.27 |
ENSMUST00000015227.3
|
C8g
|
complement component 8, gamma polypeptide |
chr5_-_116422858 | 3.25 |
ENSMUST00000036991.4
|
Hspb8
|
heat shock protein 8 |
chr17_+_84683113 | 3.21 |
ENSMUST00000045714.8
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr11_+_78499087 | 3.20 |
ENSMUST00000017488.4
|
Vtn
|
vitronectin |
chr15_+_10177623 | 3.18 |
ENSMUST00000124470.1
|
Prlr
|
prolactin receptor |
chr11_+_70054334 | 3.15 |
ENSMUST00000018699.6
ENSMUST00000108585.2 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr4_+_42629719 | 3.14 |
ENSMUST00000166898.2
|
Gm2564
|
predicted gene 2564 |
chr11_+_101367542 | 3.11 |
ENSMUST00000019469.2
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr4_-_60662358 | 3.10 |
ENSMUST00000084544.4
ENSMUST00000098046.3 |
Mup11
|
major urinary protein 11 |
chr4_-_61835185 | 3.01 |
ENSMUST00000082287.2
|
Mup5
|
major urinary protein 5 |
chr11_-_113710017 | 2.99 |
ENSMUST00000018871.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr5_+_114175889 | 2.99 |
ENSMUST00000146841.1
|
Acacb
|
acetyl-Coenzyme A carboxylase beta |
chr4_-_60499332 | 2.98 |
ENSMUST00000135953.1
|
Mup1
|
major urinary protein 1 |
chr1_+_167618246 | 2.93 |
ENSMUST00000111380.1
|
Rxrg
|
retinoid X receptor gamma |
chr1_+_88095054 | 2.89 |
ENSMUST00000150634.1
ENSMUST00000058237.7 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr4_-_42756543 | 2.88 |
ENSMUST00000102957.3
|
Ccl19
|
chemokine (C-C motif) ligand 19 |
chr14_-_51922773 | 2.84 |
ENSMUST00000089771.2
|
Rnase13
|
ribonuclease, RNase A family, 13 (non-active) |
chr11_-_78422217 | 2.82 |
ENSMUST00000001122.5
|
Slc13a2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr7_-_105600103 | 2.82 |
ENSMUST00000033185.8
|
Hpx
|
hemopexin |
chr18_+_31931470 | 2.81 |
ENSMUST00000025254.7
|
Lims2
|
LIM and senescent cell antigen like domains 2 |
chr17_+_84683131 | 2.80 |
ENSMUST00000171915.1
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr7_+_119526269 | 2.79 |
ENSMUST00000066465.1
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr9_+_46240696 | 2.77 |
ENSMUST00000034585.6
|
Apoa4
|
apolipoprotein A-IV |
chr1_-_91413163 | 2.76 |
ENSMUST00000086851.1
|
Hes6
|
hairy and enhancer of split 6 |
chr7_+_44207307 | 2.75 |
ENSMUST00000077354.4
|
Klk1b4
|
kallikrein 1-related pepidase b4 |
chr4_+_141242850 | 2.75 |
ENSMUST00000138096.1
ENSMUST00000006618.2 ENSMUST00000125392.1 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr7_-_141276729 | 2.69 |
ENSMUST00000167263.1
ENSMUST00000080654.5 |
Cdhr5
|
cadherin-related family member 5 |
chr4_-_46991842 | 2.66 |
ENSMUST00000107749.2
|
Gabbr2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr11_+_83746940 | 2.66 |
ENSMUST00000070832.2
|
1100001G20Rik
|
RIKEN cDNA 1100001G20 gene |
chr8_+_104847061 | 2.64 |
ENSMUST00000055052.5
|
Ces2c
|
carboxylesterase 2C |
chr19_+_39007019 | 2.62 |
ENSMUST00000025966.4
|
Cyp2c55
|
cytochrome P450, family 2, subfamily c, polypeptide 55 |
chr7_-_99695809 | 2.60 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr10_+_88459569 | 2.58 |
ENSMUST00000020252.3
ENSMUST00000125612.1 |
Sycp3
|
synaptonemal complex protein 3 |
chr6_-_141856171 | 2.58 |
ENSMUST00000165990.1
ENSMUST00000163678.1 |
Slco1a4
|
solute carrier organic anion transporter family, member 1a4 |
chr3_-_98630309 | 2.57 |
ENSMUST00000044094.4
|
Hsd3b5
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 |
chr2_-_30194112 | 2.55 |
ENSMUST00000113659.1
ENSMUST00000113660.1 |
Ccbl1
|
cysteine conjugate-beta lyase 1 |
chr11_-_60036917 | 2.53 |
ENSMUST00000102692.3
|
Pemt
|
phosphatidylethanolamine N-methyltransferase |
chr1_+_131797381 | 2.50 |
ENSMUST00000112393.2
ENSMUST00000048660.5 |
Pm20d1
|
peptidase M20 domain containing 1 |
chr7_-_81454751 | 2.48 |
ENSMUST00000098331.3
ENSMUST00000178892.1 |
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr11_+_16752203 | 2.48 |
ENSMUST00000102884.3
ENSMUST00000020329.6 |
Egfr
|
epidermal growth factor receptor |
chr7_-_30924169 | 2.47 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr15_-_60921270 | 2.46 |
ENSMUST00000096418.3
|
A1bg
|
alpha-1-B glycoprotein |
chr8_+_70083509 | 2.46 |
ENSMUST00000007738.9
|
Hapln4
|
hyaluronan and proteoglycan link protein 4 |
chr10_+_127801145 | 2.44 |
ENSMUST00000071646.1
|
Rdh16
|
retinol dehydrogenase 16 |
chr9_-_45204083 | 2.44 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr7_-_19698383 | 2.44 |
ENSMUST00000173739.1
|
Apoe
|
apolipoprotein E |
chr17_-_31144271 | 2.42 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr10_+_87521920 | 2.41 |
ENSMUST00000142088.1
|
Pah
|
phenylalanine hydroxylase |
chr2_+_25700039 | 2.41 |
ENSMUST00000077667.3
|
Obp2a
|
odorant binding protein 2A |
chr5_-_113081579 | 2.41 |
ENSMUST00000131708.1
ENSMUST00000117143.1 ENSMUST00000119627.1 |
Crybb3
|
crystallin, beta B3 |
chr11_+_75510077 | 2.40 |
ENSMUST00000042972.6
|
Rilp
|
Rab interacting lysosomal protein |
chr13_-_41847599 | 2.40 |
ENSMUST00000179758.1
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr19_-_46672883 | 2.39 |
ENSMUST00000026012.7
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr4_-_96664112 | 2.38 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr11_+_115462464 | 2.38 |
ENSMUST00000106532.3
ENSMUST00000092445.5 ENSMUST00000153466.1 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr15_+_82555087 | 2.35 |
ENSMUST00000068861.6
|
Cyp2d12
|
cytochrome P450, family 2, subfamily d, polypeptide 12 |
chr11_-_75422524 | 2.34 |
ENSMUST00000125982.1
ENSMUST00000137103.1 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr17_-_32947389 | 2.34 |
ENSMUST00000075253.6
|
Cyp4f13
|
cytochrome P450, family 4, subfamily f, polypeptide 13 |
chr17_+_32685655 | 2.32 |
ENSMUST00000008801.6
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr1_+_167598450 | 2.32 |
ENSMUST00000111386.1
ENSMUST00000111384.1 |
Rxrg
|
retinoid X receptor gamma |
chr11_+_97685903 | 2.32 |
ENSMUST00000107583.2
|
Cisd3
|
CDGSH iron sulfur domain 3 |
chr4_-_60582152 | 2.32 |
ENSMUST00000098047.2
|
Mup10
|
major urinary protein 10 |
chr7_-_19698206 | 2.30 |
ENSMUST00000172808.1
ENSMUST00000174191.1 |
Apoe
|
apolipoprotein E |
chr6_+_125321409 | 2.29 |
ENSMUST00000176442.1
ENSMUST00000177329.1 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr4_-_141825997 | 2.28 |
ENSMUST00000102481.3
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr4_-_107307118 | 2.26 |
ENSMUST00000126291.1
ENSMUST00000106748.1 ENSMUST00000129138.1 ENSMUST00000082426.3 |
Dio1
|
deiodinase, iodothyronine, type I |
chr17_-_32917048 | 2.25 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr11_-_113708952 | 2.25 |
ENSMUST00000106617.1
|
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr2_-_154408078 | 2.23 |
ENSMUST00000028991.6
ENSMUST00000109728.1 |
Snta1
|
syntrophin, acidic 1 |
chr16_+_13940630 | 2.23 |
ENSMUST00000141971.1
ENSMUST00000124947.1 ENSMUST00000023360.7 ENSMUST00000143697.1 |
Mpv17l
|
Mpv17 transgene, kidney disease mutant-like |
chr10_+_127866457 | 2.21 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr17_-_32947372 | 2.20 |
ENSMUST00000139353.1
|
Cyp4f13
|
cytochrome P450, family 4, subfamily f, polypeptide 13 |
chr9_+_108080436 | 2.19 |
ENSMUST00000035211.7
ENSMUST00000162886.1 |
Mst1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr11_-_70514608 | 2.19 |
ENSMUST00000021179.3
|
Vmo1
|
vitelline membrane outer layer 1 homolog (chicken) |
chr8_-_93197799 | 2.19 |
ENSMUST00000034172.7
|
Ces1d
|
carboxylesterase 1D |
chr10_+_79890853 | 2.19 |
ENSMUST00000061653.7
|
Cfd
|
complement factor D (adipsin) |
chr17_+_32685610 | 2.17 |
ENSMUST00000168171.1
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr15_-_82407187 | 2.16 |
ENSMUST00000072776.3
|
Cyp2d10
|
cytochrome P450, family 2, subfamily d, polypeptide 10 |
chr2_+_152669461 | 2.16 |
ENSMUST00000125366.1
ENSMUST00000109825.1 ENSMUST00000089059.2 ENSMUST00000079247.3 |
H13
|
histocompatibility 13 |
chr4_-_63154130 | 2.13 |
ENSMUST00000030041.4
|
Ambp
|
alpha 1 microglobulin/bikunin |
chr1_+_167598384 | 2.12 |
ENSMUST00000015987.3
|
Rxrg
|
retinoid X receptor gamma |
chr10_+_127759780 | 2.11 |
ENSMUST00000128247.1
|
RP23-386P10.11
|
Protein Rdh9 |
chr19_+_3986564 | 2.11 |
ENSMUST00000054030.7
|
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr4_+_115518264 | 2.11 |
ENSMUST00000058785.3
ENSMUST00000094886.3 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr4_-_62054112 | 2.11 |
ENSMUST00000074018.3
|
Mup20
|
major urinary protein 20 |
chr2_+_155381808 | 2.11 |
ENSMUST00000043237.7
ENSMUST00000174685.1 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr9_+_44673227 | 2.11 |
ENSMUST00000034609.4
ENSMUST00000071219.5 |
Treh
|
trehalase (brush-border membrane glycoprotein) |
chr2_-_25470031 | 2.10 |
ENSMUST00000114251.1
|
Ptgds
|
prostaglandin D2 synthase (brain) |
chr6_+_125320633 | 2.10 |
ENSMUST00000176655.1
ENSMUST00000176110.1 |
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr6_+_125321205 | 2.10 |
ENSMUST00000176365.1
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr8_+_105269788 | 2.10 |
ENSMUST00000036127.2
ENSMUST00000163734.2 |
Hsf4
|
heat shock transcription factor 4 |
chr7_-_99626936 | 2.09 |
ENSMUST00000178124.1
|
Gm4980
|
predicted gene 4980 |
chr2_+_155382186 | 2.08 |
ENSMUST00000134218.1
|
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr7_-_141434532 | 2.08 |
ENSMUST00000133021.1
ENSMUST00000106007.3 ENSMUST00000150026.1 ENSMUST00000133206.2 |
Slc25a22
|
solute carrier family 25 (mitochondrial carrier, glutamate), member 22 |
chrX_-_7681034 | 2.07 |
ENSMUST00000115695.3
|
Magix
|
MAGI family member, X-linked |
chr2_-_25500613 | 2.06 |
ENSMUST00000040042.4
|
C8g
|
complement component 8, gamma polypeptide |
chr4_-_60222580 | 2.06 |
ENSMUST00000095058.4
ENSMUST00000163931.1 |
Mup8
|
major urinary protein 8 |
chr11_+_97685794 | 2.06 |
ENSMUST00000107584.1
ENSMUST00000107585.2 |
Cisd3
|
CDGSH iron sulfur domain 3 |
chr10_+_87521795 | 2.06 |
ENSMUST00000020241.8
|
Pah
|
phenylalanine hydroxylase |
chr8_+_105269837 | 2.05 |
ENSMUST00000172525.1
ENSMUST00000174837.1 ENSMUST00000173859.1 |
Hsf4
|
heat shock transcription factor 4 |
chr1_-_136260873 | 2.04 |
ENSMUST00000086395.5
|
Gpr25
|
G protein-coupled receptor 25 |
chr9_+_57697612 | 2.03 |
ENSMUST00000034865.4
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1 |
chr17_-_84682932 | 2.03 |
ENSMUST00000066175.3
|
Abcg5
|
ATP-binding cassette, sub-family G (WHITE), member 5 |
chr1_+_88070765 | 2.02 |
ENSMUST00000073772.4
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr18_+_36664060 | 2.01 |
ENSMUST00000036765.7
|
Eif4ebp3
|
eukaryotic translation initiation factor 4E binding protein 3 |
chr12_+_85288591 | 1.98 |
ENSMUST00000059341.4
|
Zc2hc1c
|
zinc finger, C2HC-type containing 1C |
chr8_-_3717547 | 1.98 |
ENSMUST00000058040.6
|
Gm9814
|
predicted gene 9814 |
chr2_+_18672384 | 1.98 |
ENSMUST00000171845.1
ENSMUST00000061158.4 |
Commd3
|
COMM domain containing 3 |
chr6_-_141946791 | 1.98 |
ENSMUST00000168119.1
|
Slco1a1
|
solute carrier organic anion transporter family, member 1a1 |
chr17_-_24689901 | 1.97 |
ENSMUST00000007236.4
|
Syngr3
|
synaptogyrin 3 |
chr7_-_12998140 | 1.97 |
ENSMUST00000032539.7
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr5_+_137981512 | 1.96 |
ENSMUST00000035390.5
|
Azgp1
|
alpha-2-glycoprotein 1, zinc |
chr15_+_10215955 | 1.95 |
ENSMUST00000130720.1
|
Prlr
|
prolactin receptor |
chr2_+_25080316 | 1.95 |
ENSMUST00000044078.3
ENSMUST00000114380.2 |
Entpd8
|
ectonucleoside triphosphate diphosphohydrolase 8 |
chr11_-_75422586 | 1.95 |
ENSMUST00000138661.1
ENSMUST00000000769.7 |
Serpinf1
|
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
chr2_-_25469742 | 1.95 |
ENSMUST00000114259.2
ENSMUST00000015234.6 |
Ptgds
|
prostaglandin D2 synthase (brain) |
chr4_-_61674094 | 1.95 |
ENSMUST00000098040.3
|
Mup18
|
major urinary protein 18 |
chr4_+_133553370 | 1.94 |
ENSMUST00000042706.2
|
Nr0b2
|
nuclear receptor subfamily 0, group B, member 2 |
chr1_+_88055377 | 1.93 |
ENSMUST00000138182.1
ENSMUST00000113142.3 |
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr2_-_173218879 | 1.93 |
ENSMUST00000109116.2
ENSMUST00000029018.7 |
Zbp1
|
Z-DNA binding protein 1 |
chr8_-_121944886 | 1.92 |
ENSMUST00000057653.7
|
Car5a
|
carbonic anhydrase 5a, mitochondrial |
chr3_+_94693556 | 1.92 |
ENSMUST00000090848.3
ENSMUST00000173981.1 ENSMUST00000173849.1 ENSMUST00000174223.1 |
Selenbp2
|
selenium binding protein 2 |
chr3_+_94933041 | 1.92 |
ENSMUST00000090839.5
|
Selenbp1
|
selenium binding protein 1 |
chr18_-_38211957 | 1.91 |
ENSMUST00000159405.1
ENSMUST00000160721.1 |
Pcdh1
|
protocadherin 1 |
chr15_+_102445367 | 1.91 |
ENSMUST00000023809.4
|
Amhr2
|
anti-Mullerian hormone type 2 receptor |
chr4_-_60741275 | 1.90 |
ENSMUST00000117932.1
|
Mup12
|
major urinary protein 12 |
chr8_+_104733997 | 1.90 |
ENSMUST00000034346.8
ENSMUST00000164182.2 |
Ces2a
|
carboxylesterase 2A |
chr17_-_56121946 | 1.89 |
ENSMUST00000041357.7
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1 |
chr15_+_10223974 | 1.89 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr2_-_6212979 | 1.89 |
ENSMUST00000114941.1
|
Echdc3
|
enoyl Coenzyme A hydratase domain containing 3 |
chr4_-_148152059 | 1.88 |
ENSMUST00000056965.5
ENSMUST00000168503.1 ENSMUST00000152098.1 |
Fbxo6
|
F-box protein 6 |
chr7_+_44384604 | 1.88 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr4_-_61303998 | 1.88 |
ENSMUST00000071005.8
ENSMUST00000075206.5 |
Mup14
|
major urinary protein 14 |
chr11_-_113709520 | 1.87 |
ENSMUST00000173655.1
ENSMUST00000100248.4 |
Cpsf4l
|
cleavage and polyadenylation specific factor 4-like |
chr7_+_140845562 | 1.87 |
ENSMUST00000035300.5
|
Scgb1c1
|
secretoglobin, family 1C, member 1 |
chr1_+_166254095 | 1.86 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr17_+_35262730 | 1.86 |
ENSMUST00000172785.1
|
H2-D1
|
histocompatibility 2, D region locus 1 |
chr5_-_147322435 | 1.86 |
ENSMUST00000100433.4
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
chr7_-_31055594 | 1.85 |
ENSMUST00000039909.6
|
Fxyd1
|
FXYD domain-containing ion transport regulator 1 |
chr2_-_6213033 | 1.85 |
ENSMUST00000042658.2
|
Echdc3
|
enoyl Coenzyme A hydratase domain containing 3 |
chr8_-_45333189 | 1.85 |
ENSMUST00000095328.4
|
Cyp4v3
|
cytochrome P450, family 4, subfamily v, polypeptide 3 |
chr10_+_76575640 | 1.84 |
ENSMUST00000001183.7
|
Ftcd
|
formiminotransferase cyclodeaminase |
chr11_-_71019233 | 1.84 |
ENSMUST00000108523.3
ENSMUST00000143850.1 |
Derl2
|
Der1-like domain family, member 2 |
chr9_+_44107268 | 1.84 |
ENSMUST00000114821.2
ENSMUST00000114818.2 |
C1qtnf5
|
C1q and tumor necrosis factor related protein 5 |
chr17_-_34028044 | 1.84 |
ENSMUST00000045467.7
ENSMUST00000114303.3 |
H2-Ke6
|
H2-K region expressed gene 6 |
chr7_-_12998172 | 1.83 |
ENSMUST00000120903.1
|
Slc27a5
|
solute carrier family 27 (fatty acid transporter), member 5 |
chr16_-_46155077 | 1.83 |
ENSMUST00000059524.5
|
Gm4737
|
predicted gene 4737 |
chr1_+_88055467 | 1.83 |
ENSMUST00000173325.1
|
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr13_+_45078692 | 1.82 |
ENSMUST00000054395.6
|
Gm9817
|
predicted gene 9817 |
chr12_-_103958939 | 1.82 |
ENSMUST00000122229.1
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr11_+_57801575 | 1.81 |
ENSMUST00000020826.5
|
Sap30l
|
SAP30-like |
chr6_+_125321333 | 1.81 |
ENSMUST00000081440.7
|
Scnn1a
|
sodium channel, nonvoltage-gated 1 alpha |
chr13_-_41828418 | 1.80 |
ENSMUST00000137905.1
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr7_-_100662315 | 1.80 |
ENSMUST00000151123.1
ENSMUST00000107047.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr9_-_103230415 | 1.79 |
ENSMUST00000035158.9
|
Trf
|
transferrin |
chr17_-_36168532 | 1.79 |
ENSMUST00000040467.8
|
Gm8909
|
predicted gene 8909 |
chr7_+_44384098 | 1.78 |
ENSMUST00000118962.1
ENSMUST00000118831.1 |
Syt3
|
synaptotagmin III |
chr17_-_36168507 | 1.78 |
ENSMUST00000097335.3
ENSMUST00000173353.1 |
Gm8909
|
predicted gene 8909 |
chr10_+_61720592 | 1.78 |
ENSMUST00000080099.5
|
Aifm2
|
apoptosis-inducing factor, mitochondrion-associated 2 |
chr12_+_112106683 | 1.77 |
ENSMUST00000079400.4
|
Aspg
|
asparaginase homolog (S. cerevisiae) |
chr7_+_28180272 | 1.77 |
ENSMUST00000173223.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr6_-_85707858 | 1.77 |
ENSMUST00000179613.1
|
Gm4477
|
predicted gene 4477 |
chr17_+_35439155 | 1.76 |
ENSMUST00000071951.6
ENSMUST00000078205.7 ENSMUST00000116598.3 ENSMUST00000076256.7 |
H2-Q7
|
histocompatibility 2, Q region locus 7 |
chr14_-_118052235 | 1.76 |
ENSMUST00000022725.2
|
Dct
|
dopachrome tautomerase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 15.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.0 | 12.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.7 | 8.0 | GO:0060752 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
2.6 | 12.8 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.0 | 6.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
2.0 | 6.0 | GO:0006571 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
1.8 | 5.3 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
1.6 | 4.7 | GO:1903000 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
1.6 | 4.7 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
1.5 | 10.8 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.5 | 4.4 | GO:1903919 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
1.5 | 5.8 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
1.5 | 8.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.4 | 5.5 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.3 | 6.6 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
1.3 | 3.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.3 | 3.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
1.1 | 3.3 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
1.1 | 3.3 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
1.0 | 5.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.0 | 16.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.0 | 4.9 | GO:0006548 | histidine catabolic process(GO:0006548) |
1.0 | 2.9 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) |
1.0 | 10.6 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
1.0 | 7.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.0 | 3.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.9 | 3.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.9 | 7.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.8 | 2.5 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.8 | 3.3 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.8 | 1.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.8 | 2.4 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.8 | 2.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.8 | 3.9 | GO:0015886 | heme transport(GO:0015886) |
0.7 | 2.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.7 | 2.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.7 | 2.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.7 | 0.7 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.7 | 4.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.7 | 0.7 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 2.0 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.7 | 2.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 2.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.6 | 3.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.6 | 2.5 | GO:0034759 | regulation of iron ion transport(GO:0034756) negative regulation of iron ion transport(GO:0034757) regulation of iron ion transmembrane transport(GO:0034759) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.6 | 6.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 1.8 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.6 | 1.8 | GO:0002541 | plasma kallikrein-kinin cascade(GO:0002353) activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.6 | 1.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.6 | 2.4 | GO:0006001 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 1.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 3.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.6 | 1.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.6 | 1.7 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.6 | 1.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.6 | 6.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.6 | 3.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.6 | 1.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 3.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 0.6 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
0.6 | 1.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.6 | 1.7 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.6 | 2.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 1.7 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.5 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 2.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.5 | 1.6 | GO:0034034 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.5 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.5 | 3.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 3.1 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.5 | 1.0 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.5 | 1.6 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.5 | 1.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.5 | 2.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.5 | 2.5 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.5 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 1.5 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.5 | 2.0 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.5 | 4.5 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.5 | 2.0 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.5 | 3.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 1.5 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.5 | 1.5 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.5 | 3.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 1.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.5 | 2.9 | GO:0006543 | glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
0.5 | 5.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.5 | 1.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.5 | 1.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.5 | 1.8 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.5 | 4.6 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 2.7 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 1.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 1.3 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.4 | 11.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.4 | 0.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.4 | 3.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 1.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 1.3 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
0.4 | 2.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 0.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.4 | 1.7 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 1.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 3.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.4 | 0.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.4 | 2.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 2.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 1.2 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.4 | 0.8 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.4 | 9.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.4 | 1.6 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.4 | 0.4 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.4 | 4.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 1.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.4 | 1.2 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.4 | 0.4 | GO:1901950 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
0.4 | 2.3 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.4 | 1.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 1.2 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.4 | 0.8 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.4 | 2.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.4 | 0.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 1.5 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.4 | 1.1 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.4 | 2.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.4 | 2.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.1 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.4 | 3.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.4 | 2.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.5 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.4 | 1.1 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.4 | 1.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.4 | 1.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 13.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.4 | 2.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 0.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 15.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 5.0 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.4 | 1.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) negative regulation of sphingolipid biosynthesis involved in cellular sphingolipid homeostasis(GO:0090157) |
0.4 | 1.4 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.4 | 2.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 2.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 2.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.3 | 2.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 3.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 5.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 1.0 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 1.7 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 1.4 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 2.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 2.0 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.3 | 1.0 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.3 | 2.9 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.3 | 1.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 2.3 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.3 | 5.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 2.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.9 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 0.9 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.3 | 1.6 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 0.6 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.3 | 2.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.6 | GO:0016240 | autophagosome docking(GO:0016240) |
0.3 | 1.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.3 | 3.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 1.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 0.6 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.3 | 1.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 0.9 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 1.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 1.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 6.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 2.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 3.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.3 | 1.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 1.7 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 1.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 1.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.3 | 1.4 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 1.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.3 | GO:0035481 | Notch signaling pathway involved in heart induction(GO:0003137) regulation of Notch signaling pathway involved in heart induction(GO:0035480) positive regulation of Notch signaling pathway involved in heart induction(GO:0035481) |
0.3 | 0.9 | GO:0072343 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.3 | 1.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.3 | 1.4 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.3 | 5.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 0.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 0.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.8 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 1.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 2.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 0.8 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.3 | 1.6 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.3 | 0.8 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 1.1 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 3.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 1.1 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.3 | 1.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 2.4 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 1.3 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.3 | 1.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 3.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.3 | 1.9 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.8 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.3 | 0.8 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.3 | 0.5 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.3 | 2.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 2.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 6.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 3.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 0.8 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.3 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 0.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.3 | 0.8 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.3 | 2.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 1.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 0.5 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.3 | 3.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 1.2 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.2 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.0 | GO:0002587 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.2 | 6.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.7 | GO:0060084 | conditioned taste aversion(GO:0001661) synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.7 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.2 | 0.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.7 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.2 | 5.1 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.2 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 3.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.2 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.2 | 2.2 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 1.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.2 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.2 | 1.9 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 7.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.2 | 0.7 | GO:1990167 | protein K6-linked deubiquitination(GO:0044313) protein K27-linked deubiquitination(GO:1990167) |
0.2 | 1.6 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 2.6 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 0.7 | GO:0019405 | alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 3.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.9 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.2 | 0.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 0.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 0.7 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.2 | 0.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.2 | 7.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.7 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 0.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.4 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 1.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 0.7 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 0.4 | GO:0071724 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.2 | 3.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 2.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 1.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 2.0 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 1.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.7 | GO:1905204 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) cardiac muscle tissue regeneration(GO:0061026) negative regulation of connective tissue replacement(GO:1905204) |
0.2 | 1.5 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.2 | 0.7 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.2 | 0.7 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 1.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.2 | 0.4 | GO:0070256 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.2 | 3.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 2.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.2 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.2 | 0.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 1.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.6 | GO:0097402 | neuroblast migration(GO:0097402) |
0.2 | 0.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 9.6 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 1.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 2.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 10.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 1.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.0 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.2 | 1.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.2 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 6.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 0.2 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.2 | 0.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 0.8 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 2.6 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 2.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 1.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 0.2 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.2 | 0.8 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 0.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 0.8 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.2 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 1.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 0.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.2 | 0.6 | GO:1904398 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 0.6 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 0.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.8 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 3.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.8 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.2 | 1.9 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.2 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.2 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 1.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 1.3 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 0.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 0.4 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.2 | 0.7 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 0.5 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.2 | 0.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.2 | 2.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 0.7 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.2 | GO:0042335 | cuticle development(GO:0042335) |
0.2 | 1.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 0.5 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
0.2 | 0.3 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 0.5 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.2 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 0.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 2.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.2 | 0.3 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.2 | 6.8 | GO:0030104 | water homeostasis(GO:0030104) |
0.2 | 1.0 | GO:0098705 | plasma membrane copper ion transport(GO:0015679) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.2 | 0.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.5 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.2 | 0.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.2 | 0.7 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
0.2 | 2.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.7 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.2 | 1.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 1.5 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 1.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.8 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.2 | 1.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 0.7 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 1.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 6.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 0.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.6 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 1.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 1.7 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 0.5 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.2 | 0.5 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 2.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.5 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.2 | 0.9 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.9 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.5 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.2 | 0.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 1.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 2.4 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 | 2.1 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 0.5 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.2 | 2.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 1.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 7.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 4.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.7 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.9 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 3.4 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 1.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 1.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.1 | 0.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 2.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.6 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.3 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 1.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.1 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 1.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 2.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.6 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.4 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.1 | 1.9 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.4 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.1 | 1.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 1.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.1 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 1.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.5 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 2.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.3 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.1 | 1.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.4 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.1 | 0.9 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 2.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 0.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 1.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.3 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 2.8 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 1.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.6 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.8 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
0.1 | 0.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 1.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.4 | GO:0072708 | response to sorbitol(GO:0072708) |
0.1 | 2.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 2.9 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.1 | 1.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.2 | GO:0009584 | detection of visible light(GO:0009584) |
0.1 | 1.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.1 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.9 | GO:0098792 | xenophagy(GO:0098792) |
0.1 | 0.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.9 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 0.7 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.2 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.1 | 7.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.4 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.5 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 2.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 1.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.6 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:0098923 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) |
0.1 | 0.2 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 1.1 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.3 | GO:2000729 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.1 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 0.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 1.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 5.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.6 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.5 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 1.6 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 2.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.6 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.1 | 1.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.2 |